KINGMED DIAGNOSTICS GROUP CO., LTD Overview
Company Headquarters: London, UK
Founded: 1856
Workforce: ~16,000
Company Working: KingMed Diagnostics Group Co., Ltd (KingMed Diagnostics), established in 2003, is regarded as one of the leaders of the Independent Clinical Laboratories (ICL) industry in China. KingMed is the first ICL with both CAP and ISO15189 accreditation in China. By following the international quality standards and independent innovation, KingMed provides more than 2,600 tests for clinical and scientific research purposes, which represents one of the most comprehensive and integrated test menus in China. Its lab testing reports are accepted by more than 50 countries and regions worldwide. KingMed has 37 laboratories set up in mainland China and Hong Kong, covering 90% of the Chinese population. KingMed provides medical testing services for more than 22,000 medical institutions, with an annual specimen amount of over 60 million. It has built a Telepathology Network and Pathologist Group in China, which consists of more than 600 domestic and foreign pathologists. Relying on its extensive service network, excellent diagnostic capacity, and accumulated huge amount of data, KingMed has put forward a "Diagnostics+" strategy and is devoting great efforts to create a Diagnostic Ecosystem by broadening its service areas, such as In Vitro Diagnostics (IVD), Healthcare Big Data, Artificial Intelligence (AI), Forensic Testing, Clinical Trials with CRO, Physical Examination, Food and Hygiene Testing, Cold-Chain Logistics, and other services.
Strategy
KingMed Diagnostics has high quality, and international talent team specialized in research and development. By bringing well-known experts and academic leaders together from home and abroad, this team has strong R&D capacity in line with the cutting-edge international technology in medical testing. The company has strong collaborations with pharmaceutical and medical device companies.
